Proteomics

Dataset Information

0

NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome


ABSTRACT: Metabolic dysfunction is a primary feature of Werner syndrome (WS), a human premature aging disease caused by mutations in the gene encoding the Werner (WRN) DNA helicase. WS patients exhibit severe metabolic phenotypes, but the underlying mechanisms are not understood, and whether the metabolic deficit can be targeted for therapeutic intervention has not been determined. Here we report impaired mitophagy and depletion of NAD+, a fundamental ubiquitous molecule, in WS patient samples and WS invertebrate models. WRN regulates transcription of a key NAD+ biosynthetic enzyme nicotinamide nucleotide adenylyltransferase 1 (NMNAT1). NAD+ repletion restores NAD+ metabolic profiles and improves mitochondrial quality through DCT-1 and ULK-1-dependent mitophagy. At the organismal level, NAD+ repletion remarkably extends lifespan and delays accelerated aging, including stem cell dysfunction, in C. elegans and Drosophila melanogaster models of WS. Our findings suggest that accelerated aging in WRN syndrome is mediated by impaired mitochondrial function and mitophagy, and that bolstering cellular NAD+ levels counteracts WS phenotypes.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Caenorhabditis Elegans

TISSUE(S): Whole Body

SUBMITTER: Christian Koehler  

LAB HEAD: Bernd Thiede

PROVIDER: PXD015644 | Pride | 2020-01-13

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
RB_160611_Henok_NC1_1.mgf Mgf
RB_160611_Henok_NC1_1.raw Raw
RB_160611_Henok_NC1_1_F013373.dat Other
RB_160611_Henok_NC1_2.mgf Mgf
RB_160611_Henok_NC1_2.raw Raw
Items per page:
1 - 5 of 96
altmetric image

Publications


Metabolic dysfunction is a primary feature of Werner syndrome (WS), a human premature aging disease caused by mutations in the gene encoding the Werner (WRN) DNA helicase. WS patients exhibit severe metabolic phenotypes, but the underlying mechanisms are not understood, and whether the metabolic deficit can be targeted for therapeutic intervention has not been determined. Here we report impaired mitophagy and depletion of NAD<sup>+</sup>, a fundamental ubiquitous molecule, in WS patient samples  ...[more]

Similar Datasets

2019-08-16 | GSE108968 | GEO
2019-10-17 | MTBLS1221 | MetaboLights
2019-10-17 | MTBLS1223 | MetaboLights
2020-07-22 | MSV000085809 | GNPS
| PRJNA429255 | ENA
| phs000434.v1.p1 | EGA
| phs000434 | dbGaP
2014-12-31 | GSE62114 | GEO
2022-07-28 | GSE206213 | GEO
2022-07-28 | GSE206210 | GEO